XML 35 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
Beginning balance at Dec. 31, 2019 $ 675,122,000   $ 157,784,000 $ 294,999,000 $ 288,803,000   $ (21,730,000)   $ (44,734,000)
Beginning balance (Accounting Standards Update 2016-13) at Dec. 31, 2019   $ (11,047,000)       $ (11,284,000)   $ 237,000  
Beginning balance, shares at Dec. 31, 2019     29,334,629            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 46,916,000       46,916,000        
Other comprehensive income (loss), net of income tax (benefit) (651,000)           (651,000)    
Cash dividends declared (17,522,000)       (17,522,000)        
Stock-based compensation 1,353,000     1,367,000 (14,000)        
Stock issued under dividend reinvestment and employee stock purchase plans 2,369,000     (197,000)         2,566,000
Stock issued under dividend reinvestment and employee stock purchase plans, shares     140,721            
Vesting of restricted stock unit awards (70,000)     (346,000)         276,000
Vesting of restricted stock unit awards, shares     13,175            
Exercise of stock options 384,000     (55,000)         439,000
Exercise of stock options, shares     21,500            
Cancellations of performance-based restricted stock awards       418,000         (418,000)
Cancellations of performance-based restricted stock awards, shares     (14,777)            
Purchases of treasury stock (4,382,000)               (4,382,000)
Purchases of treasury stock, shares     (200,196)            
Ending balance at Dec. 31, 2020 $ 692,472,000   $ 157,784,000 296,186,000 306,899,000   (22,144,000)   (46,253,000)
Ending balance, shares at Dec. 31, 2020     29,295,052            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cash dividends declared, per share $ 0.60                
Net income $ 91,801,000       91,801,000        
Other comprehensive income (loss), net of income tax (benefit) 5,791,000           5,791,000    
Cash dividends declared (23,519,000)       (23,519,000)        
Stock-based compensation 3,457,000     3,513,000 (56,000)        
Stock issued under dividend reinvestment and employee stock purchase plans 2,384,000     153,000 (1,000)       2,232,000
Stock issued under dividend reinvestment and employee stock purchase plans, shares     86,187            
Vesting of restricted stock unit awards (355,000)     (1,153,000)         798,000
Vesting of restricted stock unit awards, shares     43,963            
Exercise of stock options 2,058,000     155,000         1,903,000
Exercise of stock options, shares     93,033            
Cancellations of performance-based restricted stock awards       327,000         (327,000)
Cancellations of performance-based restricted stock awards, shares     (7,199)            
Purchases of treasury stock (295,000)               (295,000)
Purchases of treasury stock, shares     (10,494)            
Ending balance at Dec. 31, 2021 $ 773,794,000   $ 157,784,000 299,181,000 375,124,000   (16,353,000)   (41,942,000)
Ending balance, shares at Dec. 31, 2021     29,500,542            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cash dividends declared, per share $ 0.80                
Net income $ 78,120,000       78,120,000        
Other comprehensive income (loss), net of income tax (benefit) (45,751,000)           (45,751,000)    
Cash dividends declared (24,399,000)       (24,399,000)        
Stock-based compensation 3,781,000     3,989,000 (208,000)        
Stock issued under dividend reinvestment and employee stock purchase plans 2,541,000     169,000 0       2,372,000
Stock issued under dividend reinvestment and employee stock purchase plans, shares     96,366            
Vesting of restricted stock unit awards (903,000)     (2,551,000)         1,648,000
Vesting of restricted stock unit awards, shares     92,073            
Exercise of stock options $ 698,000     20,000         678,000
Exercise of stock options, shares 32,934   32,934            
Purchases of treasury stock $ (11,381,000)               (11,381,000)
Purchases of treasury stock, shares     (450,000)            
Ending balance at Dec. 31, 2022 $ 776,500,000   $ 157,784,000 $ 300,808,000 $ 428,637,000   $ (62,104,000)   $ (48,625,000)
Ending balance, shares at Dec. 31, 2022     29,271,915            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cash dividends declared, per share $ 0.83